메뉴 건너뛰기
Clinical Nuclear Medicine
Volumn 27, Issue 7, 2002, Pages 499-502
Octreotide scans are positive in a subset of patients with hepatocellular carcinoma
Author keywords

Hepatocellular Carcinoma; Octreotide Scan; Somatostatin
Indexed keywords

PENTETREOTIDE IN 111; SOMATOSTATIN RECEPTOR;
EID: 0036661090     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003072-200207000-00007     Document Type: Article
Times cited : (10)
References (9)
  • 1
    • 0033545541 scopus 로고    scopus 로고
    • Rising incidence of hepatocellular carcinoma in the United States
    • El-Serag HB, Mason AC: Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 340:745, 1999.
    • (1999) N Engl J Med , vol.340 , pp. 745
    • El-Serag, H.B.1    Mason, A.C.2
  • 2
    • 0032532086 scopus 로고    scopus 로고
    • Treatment of hepatocellular carcinoma associated with cirrhosis in the era of liver transplantation
    • Mor E, Kapa RT, Sheiner P, et al: Treatment of hepatocellular carcinoma associated with cirrhosis in the era of liver transplantation. Ann Intern Med 129:643, 1998.
    • (1998) Ann Intern Med , vol.129 , pp. 643
    • Mor, E.1    Kapa, R.T.2    Sheiner, P.3
  • 3
    • 0016736214 scopus 로고
    • The relation of infection with the hepatitis B agent to primary hepatic carcinoma
    • Blumberg BS, Larouze B, London WT, et al: The relation of infection with the hepatitis B agent to primary hepatic carcinoma. Am J Pathol 81:669, 1975.
    • (1975) Am J Pathol , vol.81 , pp. 669
    • Blumberg, B.S.1    Larouze, B.2    London, W.T.3
  • 4
    • 0027243462 scopus 로고
    • Risk factors for hepatocellular carcinoma among patients with chronic liver disease
    • Tsukuma H, Hiyama T, Tanaka S, et al: Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 328:1797, 1993.
    • (1993) N Engl J Med , vol.328 , pp. 1797
    • Tsukuma, H.1    Hiyama, T.2    Tanaka, S.3
  • 5
    • 0032693882 scopus 로고    scopus 로고
    • Regulatory peptide receptors in human hepatocellular carcinomas
    • Reubi JC, Zimmermann A, Jonas S, et al: Regulatory peptide receptors in human hepatocellular carcinomas. Gut 45:766, 1999.
    • (1999) Gut , vol.45 , pp. 766
    • Reubi, J.C.1    Zimmermann, A.2    Jonas, S.3
  • 6
    • 0030793499 scopus 로고    scopus 로고
    • Hepatic resection enhances growth of residual intrahepatic and subcutaneous hepatoma, which is inhibited by octreotide
    • Schindel DT, Grosfeld JL: Hepatic resection enhances growth of residual intrahepatic and subcutaneous hepatoma, which is inhibited by octreotide. J Pediatr Surg 32:995, 1997.
    • (1997) J Pediatr Surg , vol.32 , pp. 995
    • Schindel, D.T.1    Grosfeld, J.L.2
  • 7
    • 0031977504 scopus 로고    scopus 로고
    • Treatment of hepatocellular carcinoma with octreotide: A randomized controlled study
    • Kouroumalis E, Skordilis P, Thermos K, et al: Treatment of hepatocellular carcinoma with octreotide: a randomized controlled study. Gut 42:442, 1998.
    • (1998) Gut , vol.42 , pp. 442
    • Kouroumalis, E.1    Skordilis, P.2    Thermos, K.3
  • 8
    • 0034202403 scopus 로고    scopus 로고
    • Treatment of hepatocellular cancer with the long acting somatostatin analog lanreotide in vitro and in vivo
    • Raderer M, Hejna MH, Muller C, et al: Treatment of hepatocellular cancer with the long acting somatostatin analog lanreotide in vitro and in vivo. Int J Oncol 16:1197, 2000.
    • (2000) Int J Oncol , vol.16 , pp. 1197
    • Raderer, M.1    Hejna, M.H.2    Muller, C.3
  • 9
    • 0034223661 scopus 로고    scopus 로고
    • Management of hepatocellular carcinoma
    • Nakakura EK, Choti MA: Management of hepatocellular carcinoma. Oncology 14:1085, 2000.
    • (2000) Oncology , vol.14 , pp. 1085
    • Nakakura, E.K.1    Choti, M.A.2

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.